These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 8361048)
1. [Detection of alterations of dihydrofolate reductase gene in folate-resistant leukemia cells by in vitro enzymatic amplification]. Miyachi H; Takemura Y; Ando Y Rinsho Byori; 1993 Jul; 41(7):779-84. PubMed ID: 8361048 [TBL] [Abstract][Full Text] [Related]
2. Differential alterations of dihydrofolate reductase gene in human leukemia cell lines made resistant to various folate analogues. Miyachi H; Takemura Y; Kobayashi H; Ando K; Ando Y Jpn J Cancer Res; 1993 Jan; 84(1):9-12. PubMed ID: 8449831 [TBL] [Abstract][Full Text] [Related]
3. Expression of variant dihydrofolate reductase with decreased binding affinity to antifolates in MOLT-3 human leukemia cell lines resistant to trimetrexate. Miyachi H; Takemura Y; Kobayashi H; Ando Y Cancer Lett; 1995 Jan; 88(1):93-9. PubMed ID: 7850779 [TBL] [Abstract][Full Text] [Related]
4. Dihydrofolate reductase gene expression characterized by the PCR assay in human leukemia cells. Miyachi H; Han H; Scanlon KJ In Vivo; 1991; 5(1):7-12. PubMed ID: 1932630 [TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of a human gene responsible for drug resistance: a rapid method for manual and automated direct sequencing of products generated by the polymerase chain reaction. Dicker AP; Volkenandt M; Adamo A; Barreda C; Bertino JR Biotechniques; 1989 Sep; 7(8):830-8. PubMed ID: 2698661 [TBL] [Abstract][Full Text] [Related]
7. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine. Thaithong S; Ranford-Cartwright LC; Siripoon N; Harnyuttanakorn P; Kanchanakhan NS; Seugorn A; Rungsihirunrat K; Cravo PV; Beale GH Exp Parasitol; 2001 Jun; 98(2):59-70. PubMed ID: 11465989 [TBL] [Abstract][Full Text] [Related]
8. Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate. Fanin R; Banerjee D; Volkenandt M; Waltham M; Li WW; Dicker AP; Schweitzer BI; Bertino JR Mol Pharmacol; 1993 Jul; 44(1):13-21. PubMed ID: 8341268 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms of resistance to antifolates, a review. Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336 [TBL] [Abstract][Full Text] [Related]
10. Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene. Takebe N; Zhao SC; Adhikari D; Mineishi S; Sadelain M; Hilton J; Colvin M; Banerjee D; Bertino JR Mol Ther; 2001 Jan; 3(1):88-96. PubMed ID: 11162315 [TBL] [Abstract][Full Text] [Related]
11. [Study on the genetic alterations in MTX-resistant cells by differential polymerase chain reaction]. Zhang Y; Deng XY; Zhang XL; Zhang GY; Li P; Fu SB Yi Chuan Xue Bao; 2003 Apr; 30(4):321-4. PubMed ID: 12812055 [TBL] [Abstract][Full Text] [Related]
13. Molecular and karyological analysis of methotrexate-resistant and -sensitive human leukemic CCRF-CEM cells. Mini E; Srimatkandada S; Medina WD; Moroson BA; Carman MD; Bertino JR Cancer Res; 1985 Jan; 45(1):317-24. PubMed ID: 3855283 [TBL] [Abstract][Full Text] [Related]
14. Specificity of ribozyme designed for mutated DHFR mRNA. Kobayashi H; Kim N; Halatsch ME; Ohnuma T Biochem Pharmacol; 1994 Apr; 47(9):1607-13. PubMed ID: 8185675 [TBL] [Abstract][Full Text] [Related]
15. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors. Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023 [TBL] [Abstract][Full Text] [Related]
16. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy]. Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358 [TBL] [Abstract][Full Text] [Related]
17. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum. Biswas S J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993 [TBL] [Abstract][Full Text] [Related]
18. Use of a semi-nested PCR diagnosis test to evaluate antifolate resistance of Plasmodium falciparum isolates. Eldin de Pecoulas P; Abdallah B; Dje MK; Basco LK; le Bras J; Mazabraud A Mol Cell Probes; 1995 Dec; 9(6):391-7. PubMed ID: 8808309 [TBL] [Abstract][Full Text] [Related]
19. Protection of CCRF-CEM human lymphoid cells from antifolates by retroviral gene transfer of variants of murine dihydrofolate reductase. Mareya SM; Sorrentino BP; Blakley RL Cancer Gene Ther; 1998; 5(4):225-35. PubMed ID: 9694074 [TBL] [Abstract][Full Text] [Related]
20. A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717). Takemura Y; Ohnuma T; Miyachi H; Sekiguchi S J Cancer Res Clin Oncol; 1991; 117(6):519-25. PubMed ID: 1683871 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]